Literature DB >> 25920516

Diagnosis and treatment of inherited thrombocytopenias.

A Pecci1.   

Abstract

Knowledge in the field of inherited thrombocytopenias (ITs) has greatly improved over the last 15 years. Several new genes responsible for thrombocytopenia have been identified leading to the definition of novel nosographic entities and to a much better characterization of the phenotypes of these diseases. To date, ITs encompass 22 disorders caused by mutations in 24 genes and characterized by different degrees of complexity and great variability in prognosis. Making a definite diagnosis is important for setting an appropriate follow-up, choosing the best treatments and providing proper counseling. Despite the abovementioned progress, diagnosis of ITs remains difficult and these disorders are still underdiagnosed. The purpose of this review is to provide an updated guide to the diagnosis of ITs based on simple procedures. Moreover, the currently available therapeutic options for these conditions are recapitulated and discussed.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  differential diagnosis; immune thrombocytopenia; inherited platelet disorders; inherited thrombocytopenia; treatment

Mesh:

Year:  2015        PMID: 25920516     DOI: 10.1111/cge.12603

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

Review 1.  Hereditary thrombocytopenias: a growing list of disorders.

Authors:  Patrizia Noris; Alessandro Pecci
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 2.  Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.

Authors:  Imo J Akpan; Afaf E G Osman; Michael W Drazer; Lucy A Godley
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 3.  Inherited Platelet Disorders: An Updated Overview.

Authors:  Verónica Palma-Barqueros; Nuria Revilla; Ana Sánchez; Ana Zamora Cánovas; Agustín Rodriguez-Alén; Ana Marín-Quílez; José Ramón González-Porras; Vicente Vicente; María Luisa Lozano; José María Bastida; José Rivera
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

4.  Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation.

Authors:  Sarah J Fletcher; Vera P Pisareva; Abdullah O Khan; Andrew Tcherepanov; Neil V Morgan; Andrey V Pisarev
Journal:  RNA       Date:  2018-04-20       Impact factor: 4.942

5.  Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial.

Authors:  Carlo Zaninetti; Paolo Gresele; Antonella Bertomoro; Catherine Klersy; Erica De Candia; Dino Veneri; Serena Barozzi; Tiziana Fierro; Maria Adele Alberelli; Valeria Musella; Patrizia Noris; Fabrizio Fabris; Carlo L Balduini; Alessandro Pecci
Journal:  Haematologica       Date:  2019-07-04       Impact factor: 9.941

Review 6.  Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases.

Authors:  Hrushikesh Vyas; Ahmad Alcheikh; Gillian Lowe; William S Stevenson; Neil V Morgan; David J Rabbolini
Journal:  Platelets       Date:  2022-05-19       Impact factor: 4.236

7.  Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia.

Authors:  Federica Melazzini; Flavia Palombo; Alessandra Balduini; Daniela De Rocco; Caterina Marconi; Patrizia Noris; Chiara Gnan; Tommaso Pippucci; Valeria Bozzi; Michela Faleschini; Serena Barozzi; Michael Doubek; Christian A Di Buduo; Katerina Stano Kozubik; Lenka Radova; Giuseppe Loffredo; Sarka Pospisilova; Caterina Alfano; Marco Seri; Carlo L Balduini; Alessandro Pecci; Anna Savoia
Journal:  Haematologica       Date:  2016-06-30       Impact factor: 9.941

8.  Pathogenetic and clinical study of a patient with thrombocytopenia due to the p.E527K gain-of-function variant of SRC.

Authors:  Serena Barozzi; Christian A Di Buduo; Caterina Marconi; Valeria Bozzi; Marco Seri; Francesca Romano; Alessandra Balduini; Alessandro Pecci
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.